Our personalized programs are designed to look at the whole person, not just a number on the scale
So, our study explored how GLP-1 receptor agonists might impact some of the top blinding diseases AMD, glaucoma, cataract in older at-risk patients. Earlier studies have indicated the drugs ability to lower risk of glaucoma, a correlation with their believed neuroprotective properties
Topics: Hypoglycemia Posted: 02 June 2023 Low blood glucose (sugar) or hypoglycemia does not always feel the same
Schedule Your Epithalon Consultation in Newport Beach If you're interested in learning more about Epithalon therapy and whether it's right for you, we invite you to schedule a consultation with Dr
Lieverse R, Jansen J, Masclee A, Lamers C
Biostatistics Primer: What a Clinician Ought to Know: Hazard Ratios